Christopher M. Bunce

Birmingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

One size does not fit all: An in vitro evaluation of the effects of bezafibrate and medroxyprogesterone acetate on human SH-SY5Y and U-87 MG cancer cells.

One size does not fit all: An in vitro evaluation of the effects of bezafibrate and medroxyprogesterone acetate on human SH-SY5Y and U-87 MG cancer cells.

Journal: FEBS open bio

Published: December 29, 2025

Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3-inflammasome activation.

Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3-inflammasome activation.

Journal: PloS one

Published: February 04, 2023

Monoclonal gammopathy of increasing significance: time to screen?

Monoclonal gammopathy of increasing significance: time to screen?

Journal: Haematologica

Published: September 10, 2020

Malonate as a ROS product is associated with pyruvate carboxylase activity in acute myeloid leukaemia cells.

Malonate as a ROS product is associated with pyruvate carboxylase activity in acute myeloid leukaemia cells.

Journal: Cancer & metabolism

Published: January 21, 2016

Tracer-Based Metabolic NMR-Based Flux Analysis in a Leukaemia Cell Line.

Tracer-Based Metabolic NMR-Based Flux Analysis in a Leukaemia Cell Line.

Journal: ChemPlusChem

Published: December 10, 2015

Tracer-Based Metabolic NMR-Based Flux Analysis in a Leukaemia Cell Line.

Tracer-Based Metabolic NMR-Based Flux Analysis in a Leukaemia Cell Line.

Journal: ChemPlusChem

Published: December 10, 2015

Knockdown of AKR1C3 exposes a potential epigenetic susceptibility in prostate cancer cells.

Knockdown of AKR1C3 exposes a potential epigenetic susceptibility in prostate cancer cells.

Journal: The Journal of steroid biochemistry and molecular biology

Published: March 14, 2015

Bezafibrate and medroxyprogesterone acetate target resting and CD40L-stimulated primary marginal zone lymphoma and show promise in indolent B-cell non-Hodgkin lymphomas.

Bezafibrate and medroxyprogesterone acetate target resting and CD40L-stimulated primary marginal zone lymphoma and show promise in indolent B-cell non-Hodgkin lymphomas.

Journal: Leukemia & lymphoma

Published: July 06, 2014

The case for extracellular Nm23-H1 as a driver of acute myeloid leukaemia (AML) progression.

The case for extracellular Nm23-H1 as a driver of acute myeloid leukaemia (AML) progression.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: April 27, 2014

Bezafibrate and medroxyprogesterone acetate in resistant and relapsed endemic Burkitt lymphoma in Malawi; an open-label, single-arm, phase 2 study (ISRCTN34303497).

Bezafibrate and medroxyprogesterone acetate in resistant and relapsed endemic Burkitt lymphoma in Malawi; an open-label, single-arm, phase 2 study (ISRCTN34303497).

Journal: British journal of haematology

Published: November 26, 2013

Proton NMR-based metabolite analyses of archived serial paired serum and urine samples from myeloma patients at different stages of disease activity identifies acetylcarnitine as a novel marker of active disease.

Proton NMR-based metabolite analyses of archived serial paired serum and urine samples from myeloma patients at different stages of disease activity identifies acetylcarnitine as a novel marker of active disease.

Journal: PloS one

Published: October 12, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026